TSS
SXTC icon

Two Sigma Securities’s China SXT Pharmaceuticals SXTC Stock Holding History

Two Sigma Securities’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$24.3K – 2002
2025
Q3 		$24.3K Buy
+1
New +$19.8K ﹤0.01% 1103
2023
Q4 		– Hold
0
– -$6.15K – 3573
2023
Q3 		– Hold
0
– – – 2767
2023
Q2 		– Hold
0
– – – 2669
2023
Q1 		– Hold
0
– – – 2535
2022
Q4 		– Hold
0
– – – 2252
2022
Q2 		– Hold
0
– -$39K – 2824
2022
Q1 		– Hold
0
– – – 1905
2021
Q4 		– Hold
0
– -$11K – 2022
2021
Q3 		– Hold
0
– – – 1488
2020
Q3 		– Hold
0
– -$10K – 1649
2020
Q2 		– Hold
0
– – – 1313

Other funds holding SXTC

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Securities's SXTC Position: Q4 2025 in Review

Two Sigma Securities sold out of China SXT Pharmaceuticals (SXTC) in Q4 2025, closing a stake of 1 share — an estimated $24.3K sold.

Two Sigma Securities first reported a position in SXTC in Q3 2025 and held it in 1 quarter. The position peaked at $24.3K in Q3 2025. 5 funds tracked by Wall St. Rank hold SXTC as of Q4 2025.

  • Two Sigma Securities reported no remaining China SXT Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1 China SXT Pharmaceuticals share in Q4 2025, an estimated $24.3K.
  • Two Sigma Securities first reported a position in China SXT Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Two Sigma Securities's China SXT Pharmaceuticals position peaked at $24.3K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.